Treatment for Subjects With Unresectable Stage III or Stage IV Melanoma

Clinical trial NCT00110994 · COMPLETED

Trial details

NCT number: NCT00110994
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cancer Melanoma

Start date: 2005-04-01
Primary completion: 2006-10-01
Enrollment: 101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.